NexgenRx Inc.
NexgenRx Inc. (NEGXF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
negxf · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for NexgenRx Inc. (NEGXF) measures how much investors pay for each dollar of the company's trailing earnings. NEGXF's current PE ratio of 9.94x is calculated by dividing its stock price of $0.20 by its TTM earnings per share of $0.03. −48.0% discount vs 5Y avg 19.1x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 5 fiscal years · Front-end computedMinQ1 · 25%21.2x
MedianQ3 · 75%33.2x
Max
At 9.94x, NEGXF's current P/E is within its average historical range over the past 5 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Healthcare Plans · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
NexgenRx Inc.You NEGXF | $14M | 9.94x | — | $0.03 |
 Abingdon Health Plc ABDXF | $32M | N/A | — | -$0.01 |
 Nurosene Health Inc. MNNDF | $14M | N/A | — | — |
 Noxopharm Limited NOXOF | $15M | N/A | — | -$0.01 |
 Simply Better Brands Corp. PKANF | $15M | N/A | — | -$0.36 |
 Poxel S.A. PXXLF | $16M | N/A | — | -$0.43 |
 RAMM Pharma Corp. RAMMF | $15M | N/A | — | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 21.20x | $0.02 | -36.1% | |
2024-12-31 FY2024 | 33.20x | $0.01 | — | |
2023-12-31 FY2023 | — | $-0.00 | — | |
2022-12-31 FY2022 | — | $-0.00 | — | |
2021-12-31 FY2021 | 7.56x | $0.06 | -6.8% | |
2020-12-31 FY2020 | 8.10x | $0.03 | — | |
2019-12-31 FY2019 | — | $-0.00 | — | |
2018-12-31 FY2018 | — | $-0.01 | — | |
2017-12-31 FY2017 | — | $-0.01 | — | |
2016-12-31 FY2016 | 25.54x | $0.01 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for NexgenRx Inc. (NEGXF) measures how much investors pay for each dollar of the company's trailing earnings. NEGXF's current PE ratio of 9.94x is calculated by dividing its stock price of $0.20 by its TTM earnings per share of $0.03.
Frequently asked questions
NEGXF pe ratio · 6 questionsNEGXF's current PE ratio is 9.94x as of 2026-06-09, based on a stock price of $0.20 and TTM EPS of $0.03. Data sourced from Financial Modeling Prep via NEGXF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · NexgenRx Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09